Literature DB >> 23150456

New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Cornelia Johanna Franziska Scheitz1, Tudorita Tumbar.   

Abstract

The transcription factor Runx1 has been studied in leukemia and blood for decades, but recently it has been also implicated in epithelial biology and pathology. Particularly in mouse skin Runx1 modulates Wnt signaling levels thereby regulating timely induction of hair follicle specification, proper maturation of the emerging adult hair follicle stem cells in embryogenesis, and timely stem cell (SC) activation during adult homeostasis. Moreover, Runx1 acts as a tumor promoter in mouse skin squamous tumor formation and maintenance, likely by repressing p21 and promoting Stat3 activation. Similarly, Runx1 is essential for oral epithelium tumorigenesis mediated in mice by Ras, and for growth of three kinds of human epithelial cancer cells. In contrast, Runx1 has a tumor suppressor function in the mouse intestine and shows tumor subtype specific behavior in human breast cancer. Multiple studies revealed Runx1 SNPs to be associated with human cancers and autoimmune disease. With this information as background, the field is poised for functional and mechanistic studies to elucidate the role of Runx1 in formation and/or progression of epithelial-based human disease.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23150456      PMCID: PMC5788165          DOI: 10.1002/jcb.24453

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  50 in total

1.  Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions.

Authors:  M C Ghozi; Y Bernstein; V Negreanu; D Levanon; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

2.  Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer.

Authors:  Shu-Pin Huang; Yu-Hsuan Lan; Te-Ling Lu; Jiunn-Bey Pao; Ta-Yuan Chang; Hong-Zin Lee; Wen-Hui Yang; Chi-Jeng Hsieh; Lu-Min Chen; Li-Chia Huang; Wen-Chien Ting; Bo-Ying Bao
Journal:  BJU Int       Date:  2010-08-24       Impact factor: 5.588

Review 3.  RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

Authors:  James K Mangan; Nancy A Speck
Journal:  Crit Rev Oncog       Date:  2011

4.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Defining the origins of Ras/p53-mediated squamous cell carcinoma.

Authors:  Andrew C White; Kathy Tran; Joan Khuu; Christine Dang; Yongyan Cui; Scott W Binder; William E Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

6.  In vitro and in vivo effects on neural crest stem cell differentiation by conditional activation of Runx1 short isoform and its effect on neuropathic pain behavior.

Authors:  Nadezda Kanaykina; Klas Abelson; Dale King; Anna Liakhovitskaia; Silke Schreiner; Michael Wegner; Elena N Kozlova
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

7.  A chromatin immunoprecipitation screen in mouse keratinocytes reveals Runx1 as a direct transcriptional target of DeltaNp63.

Authors:  Kori Ortt; Eli Raveh; Uri Gat; Satrajit Sinha
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.

Authors:  Marta Monge; Eva Colas; Andreas Doll; Marta Gonzalez; Antonio Gil-Moreno; Jesus Planaguma; Maite Quiles; Maria Antonia Arbos; Angel Garcia; Josep Castellvi; Marta Llaurado; Marina Rigau; Hafid Alazzouzi; Jordi Xercavins; Francesc Alameda; Jaume Reventos; Miguel Abal
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

9.  Runx1 modulates adult hair follicle stem cell emergence and maintenance from distinct embryonic skin compartments.

Authors:  Karen M Osorio; Karin C Lilja; Tudorita Tumbar
Journal:  J Cell Biol       Date:  2011-04-04       Impact factor: 10.539

10.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

View more
  40 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

Review 2.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

4.  Loss of RUNX1 is associated with aggressive lung adenocarcinomas.

Authors:  Jon Ramsey; Kelly Butnor; Zhihua Peng; Tim Leclair; Jos van der Velden; Gary Stein; Jane Lian; C Matthew Kinsey
Journal:  J Cell Physiol       Date:  2017-11-01       Impact factor: 6.384

5.  Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.

Authors:  H Li; X Zhao; X Yan; W J Jessen; M-O Kim; E Dombi; P P Liu; G Huang; J Wu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 6.  Precocious Phenotypic Transcription-Factor Expression During Early Development.

Authors:  Jennifer J VanOudenhove; Ricardo Medina; Prachi N Ghule; Jane B Lian; Janet L Stein; Sayyed K Zaidi; Gary S Stein
Journal:  J Cell Biochem       Date:  2017-01-11       Impact factor: 4.429

7.  Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice.

Authors:  Yukiko Komeno; Ming Yan; Shinobu Matsuura; Kentson Lam; Miao-Chia Lo; Yi-Jou Huang; Daniel G Tenen; James R Downing; Dong-Er Zhang
Journal:  Blood       Date:  2014-04-25       Impact factor: 22.113

8.  The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.

Authors:  Mamadou Keita; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

9.  MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.

Authors:  Gillian Browne; Julie A Dragon; Deli Hong; Terri L Messier; Jonathan A R Gordon; Nicholas H Farina; Joseph R Boyd; Jennifer J VanOudenhove; Andrew W Perez; Sayyed K Zaidi; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Tumour Biol       Date:  2016-01-09

10.  Defining the Teratoma as a Model for Multi-lineage Human Development.

Authors:  Daniella McDonald; Yan Wu; Amir Dailamy; Justin Tat; Udit Parekh; Dongxin Zhao; Michael Hu; Ann Tipps; Kun Zhang; Prashant Mali
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.